Physician profile
David R Bailey
NPI 1942486451
$559.94
in general payments reported to CMS, 2019-2025
11 companies · $41.47 in 2025
The $41.47 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $35.83 · 2021: $21.07 · 2022: $219 · 2023: $69.45 · 2025: $41.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $110.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $176.34 | 2020-2022 | |
| Medical Device Business Services, INC. | $115.11 | 2019 | |
| Medtronic, INC. | $103.73 | 2021-2025 | Invos, Bis |
| Chiesi USA, INC. | $34.21 | 2019 | |
| Fisher & Paykel Healthcare INC | $33.69 | 2023 | Fisher & Paykel Healthcare |
| Masimo Corporation | $23.81 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.91 | 2022 | |
| Draeger Medical Systems, INC | $18.11 | 2022 | |
| Baudax Bio INC. | $14.01 | 2022 | |
| Pacira Therapeutics, INC. | $13.99 | 2020 | |
| Ambu INC. | $8.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.